Screener
TriSalus Life Sciences, Inc. TLSI Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $12.88M+11.3% | $11.41M+1.7% | $8.9M-2.9% | $13.21M+59.8% | $11.57M+57.4% | ||
| $1.78M-6.5% | $1.51M-16.3% | $1.23M-17.7% | $1.76M+44.9% | $1.91M+89.8% | ||
| $11.1M+14.9% | $9.9M+5.2% | $7.67M0.0% | $11.44M+62.4% | $9.66M+52.2% | ||
| 86.2%+2.6pp | 86.8%+2.9pp | 86.2%+2.5pp | 86.7%+1.4pp | 83.5%-2.8pp | ||
| $3.19M-38.4% | $3.14M-20.0% | $3.22M+6.5% | $2.57M-13.1% | $5.18M+22.7% | ||
| $10.73M+56.9% | $11.42M+59.4% | $7.41M+10.1% | $7.97M+13.7% | $6.84M+11.4% | ||
| $4.88M-26.7% | $5.16M-8.8% | $5.45M+3.9% | $4.17M-10.4% | $6.66M+40.9% | ||
| -$7.71M+14.5% | -$9.81M-33.8% | -$8.41M-14.8% | -$3.27M+56.8% | -$9.01M-3.1% | ||
| -59.9%+18.1pp | -86%-20.6pp | -94.5%-14.6pp | -24.8%+67.0pp | -77.9%+41.0pp | ||
| $1.56M+6.8% | $1.49M+4.7% | $1.44M+18.8% | $1.45M+36.0% | $1.46M+27.8% | ||
| -$53K+43.6% | $90K+325% | -$76K+69.7% | -$71K+30.4% | -$94K-623% | ||
| -$8.85M+18.1% | -$9.18M-10.8% | $1.54M+115% | -$9.75M+3.5% | -$10.81M-350% | ||
| $4K-20.0% | $4K+233% | $4K-20.0% | $0— | $5K+267% | ||
| -$8.85M+18.1% | -$9.19M-10.8% | $1.54M+115% | -$9.75M+3.5% | -$10.81M-351% | ||
| -68.8%+24.7pp | -80.5%-6.6pp | 17.3%+130pp | -73.9%+48.5pp | -93.5%-60.8pp | ||
| -$0.15+84.4% | -$0.16+40.7% | $0.03+108% | -$0.12+70.0% | -$0.96-700% | ||
| -$7.58M+14.4% | -$9.68M-35.0% | -$8.28M-15.6% | -$3.15M+57.4% | -$8.85M-3.4% | ||
| -58.9%+17.7pp | -84.8%-20.9pp | -93%-14.9pp | -23.8%+65.6pp | -76.5%+39.9pp | ||
| -$7.71M+14.5% | -$9.81M-33.8% | -$8.41M-14.8% | -$3.27M+56.8% | -$9.01M-3.1% |
FAQ
- What is TriSalus Life Sciences, Inc.'s revenue?
- TriSalus Life Sciences, Inc. (TLSI) generated $46.4M in revenue over the trailing twelve months, up 15.4% year over year.
- Is TriSalus Life Sciences, Inc. profitable?
- TriSalus Life Sciences, Inc. is not currently profitable: it reported a net loss of $26.3M over the trailing twelve months, a -56.6% net margin.
- What are TriSalus Life Sciences, Inc.'s profit margins?
- Gross margin is 86.5% and operating margin is -63.0%, with a -56.6% net margin.
- What is TriSalus Life Sciences, Inc.'s earnings per share?
- TriSalus Life Sciences, Inc.'s diluted EPS over the trailing twelve months is $-0.40.
- Where does TriSalus Life Sciences, Inc.'s income statement data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
